Huntington Disease l: Introduction
Pleiotropy
Dysrhythmias III: Characteristics of Dysrhythmias
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 11, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
D J Abrams1, M A Perkin, J R Skinner
1Department of Cardiac Electrophysiology, St Bartholomew's Hosp. & Great Ormond St. Hosp. for Children, London. d.abrams@qmul.ac.uk
No abstract available in PubMed .